Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

NCT00121849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Leishmaniasis

Interventions

BIOLOGICAL: Leish-111f + MPL-SE vaccine

Sponsor

Access to Advanced Health Institute (AAHI)

Collaborators

[object Object]